226 related articles for article (PubMed ID: 12719504)
1. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program.
Menzin J; Boulanger L; Friedman M; Mackell J; Lloyd JR
Psychiatr Serv; 2003 May; 54(5):719-23. PubMed ID: 12719504
[TBL] [Abstract][Full Text] [Related]
2. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.
Gilmer TP; Dolder CR; Lacro JP; Folsom DP; Lindamer L; Garcia P; Jeste DV
Am J Psychiatry; 2004 Apr; 161(4):692-9. PubMed ID: 15056516
[TBL] [Abstract][Full Text] [Related]
3. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.
McCombs JS; Luo M; Johnstone BM; Shi L
Value Health; 2000; 3(3):222-31. PubMed ID: 16464186
[TBL] [Abstract][Full Text] [Related]
4. Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program.
Ahn J; McCombs JS; Jung C; Croudace TJ; McDonnell D; Ascher-Svanum H; Edgell ET; Shi L
Value Health; 2008; 11(1):48-56. PubMed ID: 18237360
[TBL] [Abstract][Full Text] [Related]
5. Role of patient experience in atypical antipsychotic adherence: a retrospective data analysis.
Vanelli M; Coca-Perraillon M; Troxell-Dorgan A
Clin Ther; 2007 Dec; 29(12):2768-73. PubMed ID: 18201595
[TBL] [Abstract][Full Text] [Related]
6. Use patterns for antipsychotic medications in medicaid patients with schizophrenia.
McCombs JS; Nichol MB; Stimmel GL; Shi J; Smith RR
J Clin Psychiatry; 1999; 60 Suppl 19():5-11; discussion 12-3. PubMed ID: 10507275
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics.
Lang K; Meyers JL; Korn JR; Lee S; Sikirica M; Crivera C; Dirani R; Menzin J
Psychiatr Serv; 2010 Dec; 61(12):1239-47. PubMed ID: 21123409
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic medication adherence: is there a difference between typical and atypical agents?
Dolder CR; Lacro JP; Dunn LB; Jeste DV
Am J Psychiatry; 2002 Jan; 159(1):103-8. PubMed ID: 11772697
[TBL] [Abstract][Full Text] [Related]
10. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.
Valenstein M; Blow FC; Copeland LA; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
Schizophr Bull; 2004; 30(2):255-64. PubMed ID: 15279044
[TBL] [Abstract][Full Text] [Related]
11. Continuity of antipsychotic medication management for Medicaid patients with schizophrenia.
Farley JF; Wang CC; Hansen RA; Voils CI; Maciejewski ML
Psychiatr Serv; 2011 Jul; 62(7):747-52. PubMed ID: 21724787
[TBL] [Abstract][Full Text] [Related]
12. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
[TBL] [Abstract][Full Text] [Related]
13. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.
Dolder CR; Lacro JP; Jeste DV
Psychosom Med; 2003; 65(1):156-62. PubMed ID: 12554828
[TBL] [Abstract][Full Text] [Related]
14. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
Offord S; Lin J; Mirski D; Wong B
Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
[TBL] [Abstract][Full Text] [Related]
15. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.
Weiden PJ; Kozma C; Grogg A; Locklear J
Psychiatr Serv; 2004 Aug; 55(8):886-91. PubMed ID: 15292538
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
17. Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications.
Al-Zakwani IS; Barron JJ; Bullano MF; Arcona S; Drury CJ; Cockerham TR
Curr Med Res Opin; 2003; 19(7):619-26. PubMed ID: 14606985
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of atypical antipsychotics for substance use in schizophrenia patients.
Swanson J; Van Dorn RA; Swartz MS
Schizophr Res; 2007 Aug; 94(1-3):114-8. PubMed ID: 17587548
[TBL] [Abstract][Full Text] [Related]
19. Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.
Cooper D; Moisan J; Grégoire JP
J Clin Psychiatry; 2007 Jun; 68(6):818-25. PubMed ID: 17592904
[TBL] [Abstract][Full Text] [Related]
20. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.
Nakonezny PA; Byerly MJ
Schizophr Res; 2006 Feb; 82(1):107-14. PubMed ID: 16376522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
